Hyoscine Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

1 RESEARCH SCOPE

1.1 Research Product Definition

1.2 Research Segmentation

1.2.1 Product Type

1.2.2 Main product Type of Major Players

1.3 Demand Overview

1.4 Research Methodology

2 GLOBAL HYOSCINE INDUSTRY

2.1 Summary about Hyoscine Industry

2.2 Hyoscine Market Trends

2.2.1 Hyoscine Production & Consumption Trends

2.2.2 Hyoscine Demand Structure Trends

2.3 Hyoscine Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020

3.2 Market Development under the Impact of COVID-19

3.2.1 Drivers

3.2.2 Restraints

3.2.3 Opportunity

3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)

4.1.1 North America (U.S., Canada and Mexico)

4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)

4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)

4.1.4 South America (Brazil,, Argentina, Rest of Latin America)

4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)

4.2 Product Type Segmentation (2017 to 2021f)

4.2.1 Hyoscine Butylbromide 

4.2.2 Hyoscine Hydrobromide

4.3 Consumption Segmentation (2017 to 2021f)

4.3.1 Oral 

4.3.2 Injection 

4.3.3 Patches

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)

5.1.1 U.S.

5.1.2 Canada

5.1.3 Mexico

5.2 Product Type Segmentation (2017 to 2021f)

5.2.1 Hyoscine Butylbromide 

5.2.2 Hyoscine Hydrobromide

5.3 Consumption Segmentation (2017 to 2021f)

5.3.1 Oral 

5.3.2 Injection 

5.3.3 Patches

5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)

6.1.1 Germany

6.1.2 UK

6.1.3 France

6.1.4 Italy

6.1.5 Rest of Europe

6.2 Product Type Segmentation (2017 to 2021f)

6.2.1 Hyoscine Butylbromide 

6.2.2 Hyoscine Hydrobromide

6.3 Consumption Segmentation (2017 to 2021f)

6.3.1 Oral 

6.3.2 Injection 

6.3.3 Patches

6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)

7.1.1 China

7.1.2 India

7.1.3 Japan

7.1.4 South Korea

7.1.5 Southeast Asia

7.1.6 Australia

7.1.7 Rest of Asia Pacific

7.2 Product Type Segmentation (2017 to 2021f)

7.2.1 Hyoscine Butylbromide 

7.2.2 Hyoscine Hydrobromide

7.3 Consumption Segmentation (2017 to 2021f)

7.3.1 Oral 

7.3.2 Injection 

7.3.3 Patches

7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)

8.1.1 Brazil

8.1.2 Argentina

8.1.3 Rest of Latin America

8.2 Product Type Segmentation (2017 to 2021f)

8.2.1 Hyoscine Butylbromide 

8.2.2 Hyoscine Hydrobromide

8.3 Consumption Segmentation (2017 to 2021f)

8.3.1 Oral 

8.3.2 Injection 

8.3.3 Patches

8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)

9.1.1 GCC

9.1.2 North Africa

9.1.3 South Africa

9.1.4 Rest of Middle East and Africa

9.2 Product Type Segmentation (2017 to 2021f)

9.2.1 Hyoscine Butylbromide 

9.2.2 Hyoscine Hydrobromide

9.3 Consumption Segmentation (2017 to 2021f)

9.3.1 Oral 

9.3.2 Injection 

9.3.3 Patches

9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players

10.1.1 Baxter International Inc. 

10.1.2 GlaxoSmithKline 

10.1.3 Novartis 

10.1.4 Perrigo Company 

10.1.5 Caleb Pharmaceuticals 

10.1.6 Myungmoon Pharma Co. LTD. 

10.1.7 Alchem International 

10.1.8 Centroflora-cms 

10.1.9 Guangzhou Hanfang 

10.1.10 Alkaloids Corporation 

10.1.11 Luyin

10.2 Hyoscine Sales Date of Major Players (2017-2020e)

10.2.1 Baxter International Inc. 

10.2.2 GlaxoSmithKline 

10.2.3 Novartis 

10.2.4 Perrigo Company 

10.2.5 Caleb Pharmaceuticals 

10.2.6 Myungmoon Pharma Co. LTD. 

10.2.7 Alchem International 

10.2.8 Centroflora-cms 

10.2.9 Guangzhou Hanfang 

10.2.10 Alkaloids Corporation 

10.2.11 Luyin

10.3 Market Distribution of Major Players

10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region

11.2 Forecast by Demand

11.3 Environment Forecast

11.3.1 Impact of COVID-19

11.3.2 Geopolitics Overview

11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT

Table Hyoscine Product Type Overview

Table Hyoscine Product Type Market Share List

Table Hyoscine Product Type of Major Players

Table Brief Introduction of Baxter International Inc. 

Table Brief Introduction of GlaxoSmithKline 

Table Brief Introduction of Novartis 

Table Brief Introduction of Perrigo Company 

Table Brief Introduction of Caleb Pharmaceuticals 

Table Brief Introduction of Myungmoon Pharma Co. LTD. 

Table Brief Introduction of Alchem International 

Table Brief Introduction of Centroflora-cms 

Table Brief Introduction of Guangzhou Hanfang 

Table Brief Introduction of Alkaloids Corporation 

Table Brief Introduction of Luyin

Table Products & Services of Baxter International Inc. 

Table Products & Services of GlaxoSmithKline 

Table Products & Services of Novartis 

Table Products & Services of Perrigo Company 

Table Products & Services of Caleb Pharmaceuticals 

Table Products & Services of Myungmoon Pharma Co. LTD. 

Table Products & Services of Alchem International 

Table Products & Services of Centroflora-cms 

Table Products & Services of Guangzhou Hanfang 

Table Products & Services of Alkaloids Corporation 

Table Products & Services of Luyin

Table Market Distribution of Major Players

Table Global Major Players Sales Revenue (Million USD) 2017-2020e

Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e

Table Global Hyoscine Market Forecast (Million USD) by Region 2021f-2026f

Table Global Hyoscine Market Forecast (Million USD) Share by Region 2021f-2026f

Table Global Hyoscine Market Forecast (Million USD) by Demand 2021f-2026f

Table Global Hyoscine Market Forecast (Million USD) Share by Demand 2021f-2026f